NANO2 enhances immunotherapy in triple negative breast cancers

Active Project Grant Awarded Last action

Award ID
W81XWH2210639
Recipient
Awarding agency
Obligated
$900,418

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 85% complete
Originally
Place of performance
Tucson, AZ 85719, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment NANO2 enhances immunotherapy in triple-negative breast cancers update division I and division II terms to include electronic payment instructions and… $0
Original award $900,418

Quick answers

Who received award W81XWH2210639?

W81XWH2210639 was awarded to Nuvox Pharma, L.L.C. by Defense Health Agency (Department of Defense) on August 1, 2022.

How much is award W81XWH2210639 worth?

$900,418 has been obligated on W81XWH2210639.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award